Cord blood banking facilities stores umbilical cord blood for future use in response to the potential for cord blood in treating diseases of the blood and immune systems. Cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions. Both private and public cord blood banks have developed. Cord blood stem cells are blood cell progenitors which can form red blood cells, white blood cells, and platelets and are currently used to treat blood and immune system related genetic diseases, cancers, and blood disorders.
The global cord blood banking services market report estimates the market size (Revenue USD million – 2014 to 2021) and composition of this market based on type of therapy (standard therapy for leukemia, lymphoma, blood-related disorders and metabolic diseases; and stem cell therapy for autoimmune and cardiovascular disorders, diabetes, etc.), and by ownership type (public and private) and forecasts growth trends (CAGR% – 2017 to 2021).
The global cord blood banking services market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cord blood banking services market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cord blood banking services market and included in this report are Cord Blood Registry Systems, Inc., Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., China Cord Blood Corporation and ViaCord, Inc., and others.